KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Accumulated Expenses (2016 - 2025)

CareDx (CDNA) has disclosed Accumulated Expenses for 13 consecutive years, with $41.8 million as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses rose 8.92% to $41.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $41.8 million through Dec 2025, up 8.92% year-over-year, with the annual reading at $41.8 million for FY2025, 8.92% up from the prior year.
  • Accumulated Expenses hit $41.8 million in Q4 2025 for CareDx, down from $44.0 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $49.1 million in Q4 2022 to a low of $10.5 million in Q1 2021.
  • Historically, Accumulated Expenses has averaged $29.8 million across 5 years, with a median of $28.0 million in 2021.
  • Biggest five-year swings in Accumulated Expenses: plummeted 69.23% in 2023 and later surged 228.6% in 2024.
  • Year by year, Accumulated Expenses stood at $26.0 million in 2021, then surged by 88.66% to $49.1 million in 2022, then plummeted by 59.9% to $19.7 million in 2023, then surged by 94.55% to $38.3 million in 2024, then increased by 8.92% to $41.8 million in 2025.
  • Business Quant data shows Accumulated Expenses for CDNA at $41.8 million in Q4 2025, $44.0 million in Q3 2025, and $44.0 million in Q2 2025.